1. Home
  2. ABP

as of 12-12-2025 3:07pm EST

$5.78
$0.15
-2.53%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Chart Type:
Time Range:
Founded: 2004 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 18.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 27.8K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -11.90 EPS Growth: N/A
52 Week Low/High: $4.55 - $153.90 Next Earning Date: 11-14-2025
Revenue: N/A Revenue Growth: 50.00%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered ABP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 68.97%
68.97%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Abpro Holdings Inc News

ABP Breaking Stock News: Dive into ABP Ticker-Specific Updates for Smart Investing

All ABP News

Share on Social Networks: